BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 36429110)

  • 1. S-nitrosylated PARIS Leads to the Sequestration of PGC-1α into Insoluble Deposits in Parkinson's Disease Model.
    Kim H; Lee JY; Park SJ; Kwag E; Kim J; Shin JH
    Cells; 2022 Nov; 11(22):. PubMed ID: 36429110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PARIS farnesylation prevents neurodegeneration in models of Parkinson's disease.
    Jo A; Lee Y; Kam TI; Kang SU; Neifert S; Karuppagounder SS; Khang R; Kang H; Park H; Chou SC; Oh S; Jiang H; Swing DA; Ham S; Pirooznia S; Umanah GKE; Mao X; Kumar M; Ko HS; Kang HC; Lee BD; Lee YI; Andrabi SA; Park CH; Lee JY; Kim H; Kim H; Kim H; Cho JW; Paek SH; Na CH; Tessarollo L; Dawson VL; Dawson TM; Shin JH
    Sci Transl Med; 2021 Jul; 13(604):. PubMed ID: 34321320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PARIS (ZNF746) repression of PGC-1α contributes to neurodegeneration in Parkinson's disease.
    Shin JH; Ko HS; Kang H; Lee Y; Lee YI; Pletinkova O; Troconso JC; Dawson VL; Dawson TM
    Cell; 2011 Mar; 144(5):689-702. PubMed ID: 21376232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutual exacerbation of peroxisome proliferator-activated receptor γ coactivator 1α deregulation and α-synuclein oligomerization.
    Eschbach J; von Einem B; Müller K; Bayer H; Scheffold A; Morrison BE; Rudolph KL; Thal DR; Witting A; Weydt P; Otto M; Fauler M; Liss B; McLean PJ; Spada AR; Ludolph AC; Weishaupt JH; Danzer KM
    Ann Neurol; 2015 Jan; 77(1):15-32. PubMed ID: 25363075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promotion of mitochondrial biogenesis via the regulation of PARIS and PGC-1α by parkin as a mechanism of neuroprotection by carnosic acid.
    Lin CY; Huang YN; Fu RH; Liao YH; Kuo TY; Tsai CW
    Phytomedicine; 2021 Jan; 80():153369. PubMed ID: 33070082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PINK1 Primes Parkin-Mediated Ubiquitination of PARIS in Dopaminergic Neuronal Survival.
    Lee Y; Stevens DA; Kang SU; Jiang H; Lee YI; Ko HS; Scarffe LA; Umanah GE; Kang H; Ham S; Kam TI; Allen K; Brahmachari S; Kim JW; Neifert S; Yun SP; Fiesel FC; Springer W; Dawson VL; Shin JH; Dawson TM
    Cell Rep; 2017 Jan; 18(4):918-932. PubMed ID: 28122242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PGC-1α activity in nigral dopamine neurons determines vulnerability to α-synuclein.
    Ciron C; Zheng L; Bobela W; Knott GW; Leone TC; Kelly DP; Schneider BL
    Acta Neuropathol Commun; 2015 Apr; 3():16. PubMed ID: 25853296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. REST Protects Dopaminergic Neurons from Mitochondrial and α-Synuclein Oligomer Pathology in an Alpha Synuclein Overexpressing BAC-Transgenic Mouse Model.
    Ryan BJ; Bengoa-Vergniory N; Williamson M; Kirkiz E; Roberts R; Corda G; Sloan M; Saqlain S; Cherubini M; Poppinga J; Bogtofte H; Cioroch M; Hester S; Wade-Martins R
    J Neurosci; 2021 Apr; 41(16):3731-3746. PubMed ID: 33563726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repression of rRNA transcription by PARIS contributes to Parkinson's disease.
    Kang H; Shin JH
    Neurobiol Dis; 2015 Jan; 73():220-8. PubMed ID: 25315684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detrimental effects of oxidative losses in parkin activity in a model of sporadic Parkinson's disease are attenuated by restoration of PGC1alpha.
    Siddiqui A; Rane A; Rajagopalan S; Chinta SJ; Andersen JK
    Neurobiol Dis; 2016 Sep; 93():115-20. PubMed ID: 27185595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic alpha-synuclein fibrils cause mitochondrial impairment and selective dopamine neurodegeneration in part via iNOS-mediated nitric oxide production.
    Tapias V; Hu X; Luk KC; Sanders LH; Lee VM; Greenamyre JT
    Cell Mol Life Sci; 2017 Aug; 74(15):2851-2874. PubMed ID: 28534083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ZNF746/PARIS promotes the occurrence of hepatocellular carcinoma.
    Kim H; Lee JY; Park SJ; Kwag E; Koo O; Shin JH
    Biochem Biophys Res Commun; 2021 Jul; 563():98-104. PubMed ID: 34062393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysregulation of parkin in the substantia nigra of db/db and high-fat diet mice.
    Khang R; Park C; Shin JH
    Neuroscience; 2015 May; 294():182-92. PubMed ID: 25779963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained expression of PGC-1α in the rat nigrostriatal system selectively impairs dopaminergic function.
    Ciron C; Lengacher S; Dusonchet J; Aebischer P; Schneider BL
    Hum Mol Genet; 2012 Apr; 21(8):1861-76. PubMed ID: 22246294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transgenic expression and activation of PGC-1α protect dopaminergic neurons in the MPTP mouse model of Parkinson's disease.
    Mudò G; Mäkelä J; Di Liberto V; Tselykh TV; Olivieri M; Piepponen P; Eriksson O; Mälkiä A; Bonomo A; Kairisalo M; Aguirre JA; Korhonen L; Belluardo N; Lindholm D
    Cell Mol Life Sci; 2012 Apr; 69(7):1153-65. PubMed ID: 21984601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adult Conditional Knockout of PGC-1α Leads to Loss of Dopamine Neurons.
    Jiang H; Kang SU; Zhang S; Karuppagounder S; Xu J; Lee YK; Kang BG; Lee Y; Zhang J; Pletnikova O; Troncoso JC; Pirooznia S; Andrabi SA; Dawson VL; Dawson TM
    eNeuro; 2016; 3(4):. PubMed ID: 27622213
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PARIS undergoes liquid-liquid phase separation and poly(ADP-ribose)-mediated solidification.
    Kang H; Park S; Jo A; Mao X; Kumar M; Park CH; Ahn JY; Lee Y; Choi JY; Lee YS; Dawson VL; Dawson TM; Kam TI; Shin JH
    EMBO Rep; 2023 Nov; 24(11):e56166. PubMed ID: 37870275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MitoQ protects dopaminergic neurons in a 6-OHDA induced PD model by enhancing Mfn2-dependent mitochondrial fusion via activation of PGC-1α.
    Xi Y; Feng D; Tao K; Wang R; Shi Y; Qin H; Murphy MP; Yang Q; Zhao G
    Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):2859-2870. PubMed ID: 29842922
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PGC-1α Promoter Methylation in Parkinson's Disease.
    Su X; Chu Y; Kordower JH; Li B; Cao H; Huang L; Nishida M; Song L; Wang D; Federoff HJ
    PLoS One; 2015; 10(8):e0134087. PubMed ID: 26317511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of transketolase as a target of PARIS in substantia nigra.
    Kim H; Kang H; Lee Y; Park CH; Jo A; Khang R; Shin JH
    Biochem Biophys Res Commun; 2017 Nov; 493(2):1050-1056. PubMed ID: 28939041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.